Author: Tadeáš Kouřil 6 min read

Effectiveness of CBD Use in Treating Amyotrophic Lateral Sclerosis (ALS)

This is a neurodegenerative disorder, with the aim of focusing treatment on neural connections in the brain, which are, among others, also the center for controlling motor functions. Various alternative means supporting standard medication are increasingly coming to the fore, including CBD as a cannabinoid substance contained in medicinal cannabis. What can it offer to patients with this disease?

Amyotrophic Lateral Sclerosis: A Challenge for Modern Medicine

Amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, remains one of the most complex neurodegenerative diseases that science has to contend with. This progressive condition mainly affects people between 40 and 70 years old and is characterized by the gradual degeneration of the motor neurons that control muscle movement.

The best-known ALS patient was undoubtedly the theoretical physicist Stephen Hawking, whose story drew worldwide attention to this exhausting disease. In ALS, the connection between brain and muscles is disrupted, leading to a progressive loss of muscle function. Those affected gradually lose control over their limbs, their speech, and eventually even their breathing, as the respiratory muscles are affected as well.

Recognizing the Symptoms of ALS

The first signs of ALS appear in different ways. Many patients first notice muscle weakness in the hands or feet, followed by muscle cramps and involuntary muscle twitching. As the disease progresses, increasingly complex functions are affected too:

  • Progressive muscle weakness, starting in the extremities
  • Impaired motor control of the arms and legs
  • Spasticity and fasciculations in various muscle groups
  • Breathing and swallowing difficulties
  • Speech disorders and articulation problems
  • Increased salivation
  • Sleep disturbances and muscle pain

Causes and Diagnostic Challenges

The causes of ALS remain largely unclear, even though research has identified several risk factors. Genetic predisposition plays an important role: in around 10% of cases a clear hereditary component can be identified. In addition, environmental factors, oxidative stress, autoimmune processes and viral infections are being studied as possible triggers.

Diagnosing ALS presents a considerable challenge, since there is no specific test for it. Doctors must systematically rule out other neurodegenerative diseases, among other things through electromyography, imaging of the central nervous system and extensive laboratory tests.

Current Treatment Strategies

Although there is still no cure for ALS, therapeutic measures aim to relieve symptoms and slow the progression of the disease. Current pharmacological options include riluzole, which modulates glutamate levels, and edaravone, an antioxidant with neuroprotective properties.

Multidisciplinary treatment teams offer supportive therapies such as physiotherapy to preserve muscle function, speech therapy for communication problems, and respiratory support for breathing difficulties. This holistic approach helps patients maintain their independence for as long as possible.

Cannabis Genetics and Cannabinoid Research

In the context of neurodegenerative diseases, CBD-rich cannabis genetics show fascinating properties that draw scientific interest. These collector's seeds contain complex cannabinoid and terpene profiles that researchers study because of their unique biochemical composition.

CBD (cannabidiol) is one of the best-researched non-psychoactive cannabinoids in cannabis genetics. This compound interacts with the endocannabinoid system by binding to CB1 and CB2 receptors, as well as with other molecular targets such as TRPV1 channels and serotonin receptors.

Collector's seeds of CBD-dominant cultivars often also have interesting terpene profiles, including myrcene, limonene and beta-caryophyllene. These aromatic molecules contribute to the complex bouquet of scents and flavors that makes cannabis genetics so fascinating for collectors and researchers alike.

Biochemical Properties of Cannabis Genetics

The genetic diversity within cannabis species results in a broad spectrum of cannabinoid and terpene expressions. Modern breeding programs have developed cultivars with specific chemical profiles that are of scientific interest. These collector's seeds represent centuries of selective breeding and genetic preservation.

The endocannabinoid system, which is involved in homeostasis and neuronal signaling, is an active field of research for neurologists and biochemists. Cannabis genetics provide a natural source of ligands for this complex biological network, which explains why this plant is such a rich field of study.

Future Perspectives in Neurological Research

Research into neurodegenerative diseases such as ALS is constantly evolving, with new therapeutic targets being identified regularly. Research into the endocannabinoid system and neuroinflammation is opening up new perspectives for understanding complex neurological processes.

Cannabis genetics remain a valuable resource for biochemical research, with collector's seeds serving as genetic material for scientific studies. Preserving this genetic diversity is essential for future research into plant compounds and their molecular properties.

Looking ahead to future developments in neurology, interdisciplinary collaboration between plant genetics, biochemistry and medicine remains essential for unlocking new therapeutic possibilities. The complex interactions between cannabinoids, terpenes and biological systems form a fascinating frontier of modern science.